Q4 EPS Estimates for Aurora Cannabis Reduced by Roth Capital

Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) - Equities researchers at Roth Capital decreased their Q4 2025 earnings per share (EPS) estimates for shares of Aurora Cannabis in a report released on Thursday, February 6th. Roth Capital analyst W. Kirk now expects that the company will earn $0.27 per share for the quarter, down from their prior estimate of $0.40. The consensus estimate for Aurora Cannabis' current full-year earnings is ($0.10) per share. Roth Capital also issued estimates for Aurora Cannabis' FY2026 earnings at $0.88 EPS.

Aurora Cannabis (NASDAQ:ACB - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%.

Other analysts have also recently issued reports about the company. TD Securities raised Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th. Atb Cap Markets raised shares of Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 5th. Finally, TD Cowen initiated coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They set a "buy" rating for the company.

Aurora Cannabis Stock Up 4.6 %

ACB stock traded up $0.29 during mid-day trading on Monday, reaching $6.62. The company had a trading volume of 2,996,783 shares, compared to its average volume of 4,604,232. The company has a market capitalization of $363.17 million, a price-to-earnings ratio of 132.43 and a beta of 1.84. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The stock has a 50 day simple moving average of $4.44 and a two-hundred day simple moving average of $5.18. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.30 and a quick ratio of 1.88.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ACB. SBI Securities Co. Ltd. acquired a new position in shares of Aurora Cannabis in the 4th quarter valued at about $31,000. Cubist Systematic Strategies LLC bought a new position in shares of Aurora Cannabis during the 2nd quarter worth approximately $50,000. Edmond DE Rothschild Holding S.A. bought a new stake in shares of Aurora Cannabis in the 4th quarter valued at $88,000. Tidal Investments LLC boosted its stake in Aurora Cannabis by 2.7% during the third quarter. Tidal Investments LLC now owns 1,344,321 shares of the company's stock worth $7,905,000 after acquiring an additional 34,988 shares in the last quarter. Finally, Wealthspire Advisors LLC bought a new stake in Aurora Cannabis in the fourth quarter valued at $149,000. Institutional investors and hedge funds own 47.63% of the company's stock.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.